Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas

BACKGROUND: The aim of this study was to compare clinical and pathological outcomes after neoadjuvant chemotherapy between oestrogen receptor (ER)-positive invasive pure lobular carcinoma (ILC) and invasive ductal carcinoma (IDC). METHODS: This analysis included 1895 patients (n=177 ILC; n=1718 IDC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Delpech, Y, Coutant, C, Hsu, L, Barranger, E, Iwamoto, T, Barcenas, C H, Hortobagyi, G N, Rouzier, R, Esteva, F J, Pusztai, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566807/
https://www.ncbi.nlm.nih.gov/pubmed/23299541
http://dx.doi.org/10.1038/bjc.2012.557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566807/
https://www.ncbi.nlm.nih.gov/pubmed/23299541
http://dx.doi.org/10.1038/bjc.2012.557

Ejemplares similares